Inhibitors of the peptidyl-prolyl cis/trans isomerase (PIN1), combinations and uses thereof. WO/2023/278603. January 5 2023.
Small-molecule Focal Adhesion Kinase (FAK) inhibitors. WO/2020/231726. November 19 2020.
Degradation of FAK or FAK and ALK by conjugation of FAK and ALK inhibitiors with E3 ligase ligands and methods of use. WO/2020/069117. April 2 2020.
Regulating chimeric antigen receptors. WO/2018/148440. August 16 2018.
Tunable endogenous protein degradation with heterobifunctional small molecules. WO/2018/148443. August 16 2018.
Targeted protein degradation to attenuate adoptive t-cell therapy associated adverse inflammatory responses. WO/2017/024318. February 9 2017.
Tunable endogenous protein degradation. WO/2017/024319. February 9 2017.